| Literature DB >> 35814327 |
Faizan A Ansari1, Muzamil Latief2, Sonu Manuel1, K B Shashikiran1, Rohan Dwivedi1, D K Prasad1, Anvesh Golla1, Sree B Raju1.
Abstract
Introduction: The impact of Ramadan fasting in patients with chronic kidney disease (CKD) remains less studied and with inconsistent results. In this study, we tried to look at the impact of Ramadan fasting on renal function in patients with CKD. Materials andEntities:
Keywords: CKD; Ramadan; fasting; renal impairment
Year: 2022 PMID: 35814327 PMCID: PMC9267091 DOI: 10.4103/ijn.IJN_521_20
Source DB: PubMed Journal: Indian J Nephrol ISSN: 0971-4065
Weight and blood pressure before and after Ramadan
| Before Ramadan | After Ramadan |
| |
|---|---|---|---|
| Weight (kg) | 62±11.6 | 61.3±11.4 | 1.188 |
| SBP (mmHg) | 140.6±11.1 | 129.7±9.2 | 2.008 |
| DBP (mmHg) | 86.7±6.8 | 79.1±5.6 | 4.155 |
SBP=systolic blood pressure; DBP=diastolic blood pressure
Renal and biochemical variables
| Before Ramadan | During Ramadan | After Ramadan |
| |
|---|---|---|---|---|
| Urea (mg%) | 40.2±22.2 | 43.4±22.1 | 0.208 | |
| Creatinine (mg%) | 1.7±0.9 | 1.8±0.95 | 1.68±0.95 | 0.021 |
| GFR (mL/minute) | 56.1±33.3 | 51.4±30.3 | 54.5±30.8 | 0.0052 |
| Fasting sugar (mg/dL) | 116.2±34.6 | 109.6±26.8 | 0.371 | |
| Hemoglobin (g/dL) | 11.6±4.9 | 12.9±2.3 | 0.011 | |
| PCV | 36.3±6.4 | 38.5±6.5 | 0.001 | |
| Sodium (mmol/L) | 138.1±2.9 | 137.8±2.8 | 0.571 | |
| Potassium (mmol/L) | 4.3±0.6 | 4.5±0.5 | 0.022 | |
| Calcium (mg/dL) | 9.3±0.6 | 9.5±0.5 | 0.042 | |
| Phosphorus (mg/dL) | 3.7±0.6 | 3.6±0.7 | 0.257 | |
| Uric acid (mg/dL) | 5.8±1.8 | 6.3±1.9 | 0.183 | |
| Magnesium (mg/dL) | 0.8±0.07 | 0.8±0.07 | 0.330 | |
| Albumin (g/dL) | 4.1±0.4 | 4.2±0.3 | 0.381 | |
| Cholesterol (mg/dL) | 143.7±33 | 144.9±40.5 | 0.753 | |
| Triglycerides (mg/dL) | 109.6±41.6 | 112.1±47 | 0.522 |
GFR=Glomerular filtration rate; PCV=packed cell volume
Urinary parameters before and after Ramadan
| Before Ramadan | During Ramadan | After Ramadan |
| |
|---|---|---|---|---|
| Urine volume (mL/day) | 1990±368 | 1425±253 | 1857±267 | 0.001 |
| Urine Ph | 5.63±0.6 | 5.7±0.7 | 0.698 | |
| Urine specific gravity | 1.015±0.008 | 1.013±0.007 | 0.424 | |
| Protein/creatinine (g/mg) | 0.6±0.5 | 0.61±0.5 | 0.830 |
Figure 1Estimated glomerular filtration rate (eGFR) changes during study
Effect of fasting on the development of worsening renal function (WRF)
| CKD Stage | Number (%) | WRF |
|---|---|---|
| I | 6 (21.4) | 0 |
| II | 5 (17.85) | 0 |
| III | 9 (32.1) | 0 |
| IV | 6 (21.4) | 3 (50%) |
| V (ND) | 2 (7.1) | 1 (50%) |
CKD=Chronic kidney disease; ND=Non dialysis
Comparison of CKD stages and baseline parameters with other studies
| Parameters | Bernieh | Bakhit | Our study |
|---|---|---|---|
| Year | 2005 | 2017 | 2019 |
|
| 31 | 65 | 28 |
| Season | Winter | Summer | Summer |
| CKD 3, | 14 (45.2) | 36 (55.4) | 9 (32.1) |
| CKD 4, | 12 (38.7) | 24 (37) | 6 (21.4) |
| CKD 5, | 5 (16.1) | 5 (7.7) | 2 (7.1) |
| Mean age (years) | 54±4.2 | 53.1±15.2 | 46±12 |
| Male gender (%) | 61.3 | 61.5 | 35.7 |
| Weight (kg) | 76.4±18 | 78.41±7.4 | 62±11 |
| GFR (mL/min) | 29±16.3 | 31.1±13.3 | 56.1±33.3 |
| Diabetes (%) | 61 | 38.5 | 36 |
| Hypertension (%) | 71 | 89.2 | 93 |
CKD=chronic kidney disease; GFR=glomerular filtration rate